Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold

Tissue Engineering - Part A

Volumn 17, Issue 7-8, 2011, Pages 969-979

  Zhao, Liang ^a   Tang, Minghui ^a   Weir, Michael D ^a   Detamore, Michael S ^b   Xu, Hockin H K ^a,c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Kansas   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Baltimore County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; BONE CEMENT; CALCIUM; CALCIUM PHOSPHATE; CELL CULTURE; CEMENTS; CHITIN; CHITOSAN; GENE EXPRESSION; HYDROGELS; HYDROLASES; MINERALOGY; PHOSPHATASES; PHOSPHATES; SCAFFOLDS (BIOLOGY);

ABSORBABLE FIBERS; ALGINATE HYDROGELS; ALKALINE PHOSPHATASE; BONE MARROW; BONE MINERALS; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE CEMENT; CONTROL CONSTRUCTS; FIBROUS SCAFFOLDS; HUMAN UMBILICAL CORD; MESENCHYMAL STEM CELL; MICROBEADS; MINIMALLY INVASIVE; ORTHOPEDIC SURGERY; OSTEOCALCIN; OSTEODIFFERENTIATION; OSTEOGENIC; OSTEOGENIC MEDIA; OSTERIX; PROTEIN SYNTHESIS; RHBMP-2; UMBILICAL CORDS; WORLD POPULATION;

STEM CELLS;

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID; MICROSPHERE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; COLORIMETRY; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; METHODOLOGY; TISSUE ENGINEERING; UMBILICAL CORD;

ALGINATES; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; COLORIMETRY; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MESENCHYMAL STEM CELLS; MICROSPHERES; OSTEOGENESIS; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA; UMBILICAL CORD;

EID: 79952932827     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0521     Document Type: Article

References (58)

1. Lavik, E., and Langer, R. Tissue engineering: current state and perspectives. Appl Microbiol Biotech 65, 1, 2004.
2. Mao, J.J., Giannobile, W.V., Helms, J.A., Hollister, S.J., Krebsbach, P.H., Longaker, M.T., and Shi, S. Craniofacial tissue engineering by stem cells. J Dent Res 85, 966, 2006.
3. Salinas, C.N., and Anseth, K.S. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med 2, 296, 2008.
4. Kretlow, J.D., Young, S., Klouda, L., Wong, M., and Mikos, A.G. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 21, 3368, 2009.
5. Laurencin, C.T., Ambrosio, A.M.A., Borden, M.D., and Cooper, J.A. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1, 19, 1999.
6. Santos, E.M., Radin, S., Shenker, B.J., Shapiro, I.M., and Ducheyne, P. Si-Ca-P xerogels and bone morphogenetic protein act synergistically on rat stromal marrow cell differentiation in vitro. J Biomed Mater Res 41, 87, 1998.
7. Mao, J.J., Vunjak-Novakovic, G., Mikos, A.G., and Atala, A. Regenerative Medicine: Translational Approaches and Tissue Engineering, Chapter 1-3. Boston and London: Artech House, 2007.
8. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., Schoen, F.J., Toner, M., Mooney, D., Atala, A., van Dyke, M.E., Kaplan, D., and Vunjak-Novakovic, G. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
9. Kong, H.J., Smith, M.K., and Mooney, D.J. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 24, 4023, 2003.
10. Wang, H.S., Hung, S.C., and Peng, S.T. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330, 2004.
11. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M.M., and Davies, J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220, 2005.
12. Can, A., and Karahuseyinoglu, S. Concise review: Human umbilical cord stroma with regard to the source of fetusderived stem cells. Stem Cells 25, 2886, 2007.
13. Baksh, D., Yao, R., and Tuan, R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25, 1384, 2007.
14. Bailey, M.M., Wang, L., Bode, C.J., Mitchell, K.E., and Detamore, M.S. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 13, 2003, 2007.
15. Karahuseyinoglu, S., Kocaefe, C., Balci, D., Erdemli, E., and Can, A. Functional structure of adipocytes differentiated from human umbilical cord stroma-derived stem cells. Stem Cells 26, 682, 2008.
16. Wang, L., Singh, M., Bonewald, L.F., and Detamore, M.S. Signaling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med 3, 398, 2009.
17. Weiss, M.L., Medicetty, S., Bledsoe, A.R., Rachakatla, R.S., Choi, M., Merchav, S., Luo, Y., Rao, M.S., Velagaleti, G., and Troyer, D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781, 2006.
18. Jäger, M., Degistirici, O., Knipper, A., Fischer, J., Sager, M., and Krauspe, R. Bone healing and migration of cord bloodderived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 22, 1224, 2007.
19. Zhao, L., Burguera, E.F., Xu, H.H.K., Amin, N., Ryou, H., and Arola, D.D. Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosanbiodegradable fiber scaffolds. Biomaterials 31, 840, 2010.
20. Ducheyne, P., and Qiu, Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 20, 2287, 1999.
21. Foppiano, S., Marshall, S.J., Marshall, G.W., Saiz, E., and Tomsia, A.P. The influence of novel bioactive glasses on in vitro osteoblast behavior. J Biomed Mater Res A 71, 242, 2004.
22. Deville, S., Saiz, E., Nalla, R.K., and Tomsia, A.P. Freezing as a path to build complex composites. Science 311, 515, 2006.
23. Reilly, G.C., Radin, S., Chen, A.T., and Ducheyne, P. Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials 28, 4091, 2007.
24. Brown, W.E., and Chow, L.C. A new calcium phosphate water setting cement. In: Brown, P.W., ed. Cements Research Progress. Westerville, OH: American Ceramic Society, 1986, pp. 352-379.
25. Barralet, J.E., Gaunt, T., Wright, A.J., Gibson, I.R., and Knowles, J.C. Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement. J Biomed Mater Res B 63, 1, 2002.
26. Bohner, M., and Baroud, G. Injectability of calcium phosphate pastes. Biomaterials 26, 1553, 2005.
27. Link, D.P., van den Dolder, J., van den Beucken, J.J., Wolke, J.G., Mikos, A.G., and Jansen, J.A. Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-b1 loaded gelatin microspheres. Biomaterials 29, 675, 2008.
28. Shindo, M.L., Costantino, P.D., Friedman, C.D., and Chow, L.C. Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 119, 185, 1993.
29. Friedman, C.D., Costantino, P.D., Takagi, S., and Chow, L.C. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res B 43, 428, 1998.
30. Simon, C.G., Jr., Guthrie, W.F., and Wang, F.W. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 68, 628, 2004.
31. Weir, M.D., Xu, H.H.K., and Simon, C.G., Jr. Strong calcium phosphate cement-chitosan-mesh construct containing cellencapsulating hydrogel beads for bone tissue engineering. J Biomed Mater Res A 77, 487, 2006.
32. Zhao, L., Weir, M.D., and Xu, H.H.K. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 31, 3848, 2010.
33. Zhao, L., Weir, M.D., and Xu, H.H.K. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 31, 6502, 2010.
34. Karageorgiou, V., Tomkins, M., Fajardo, R., Meinel, L., Snyder, B., Wade, K., Chen, J., Vunjak-Novakovic, G., and Kaplan, D.L. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78, 324, 2006.
35. Benoit, D.S., Collins, S.D., and Anseth, K.S. Multifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. Adv Funct Mater 17, 2085, 2007.
36. Park, E.J., Kim, E.S., Weber, H.P., Wright, R.F., and Mooney, D.J. Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2. Int J Oral Maxillofac Implants 23, 818, 2008.
37. Young, S., Patel, Z.S., Kretlow, J.D., Murphy, M.B., Mountziaris, P.M., Baggett, L.S., Ueda, H., Tabata, Y., Jansen, J.A., Wong, M., and Mikos, A.G. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15, 2347, 2009.
38. Reyes, J.M., Fermanian, S., Yang, F., Zhou, S.Y., Herretes, S., Murphy, D.B., Elisseeff, J.H., and Chuck, R.S. Metabolic changes in mesenchymal stem cells in osteogenic medium measured by autofluorescence spectroscopy. Stem Cells 24, 1213, 2006.
39. Nuttelman, C.R., Tripodi, M.C., and Anseth, K.S. Dexamethasonefunctionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A 76, 183, 2006.
40. Xu, H.H.K., Takagi, S., Quinn, J.B., and Chow, L.C. Fastsetting and anti-washout calcium phosphate scaffolds with high strength and controlled macropore formation rates. J Biomed Mater Res A 68, 725, 2004.
41. Muzzarelli, R.A.A., Biagini, G., Bellardini, M., Simonelli, L., Castaldini, C., and Fraatto, G. Osteoconduction exerted by methylpyrolidinone chitosan in dental surgery. Biomaterials 14, 39, 1993.
42. Xu, H.H.K., and Simon, C.G., Jr. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 26, 1337, 2005.
43. Zhang, Y., and Xu, H.H.K. Effects of synergistic reinforcement and absorbable fiber strength on hydroxyapatite bone cement. J Biomed Mater Res A 75, 832, 2005.
44. Ruhé, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 85, 75, 2003.
45. Jansen, J.A., Vehof, J.W.M., Ruhé, P.Q., Kroeze-Deutman, H., Kuboki, Y., Takita, H., Hedberg, E.L., and Mikos, A.G. Growth factor-loaded scaffolds for bone engineering. J Controlled Release 101, 127, 2005.
46. Moreau, J.L., and Xu, H.H.K. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan scaffold. Biomaterials 30, 2675, 2009.
47. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402, 2001.
48. Kim, K., Dean, D., Mikos, A.G., and Fisher, J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on crosslinked poly(propylene fumarate) disks. Biomacromolecules 10, 1810, 2009.
49. Wang, Y.H., Liu, Y., Maye, P., and Rowe, D.W. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog 22, 1697, 2006.
50. Drury, J.L., and Mooney, D.J. Review. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24, 4337, 2003.
51. Drury, J.L., Dennis, R.G., and Mooney, D.J. The tensile properties of alginate hydrogels. Biomaterials 25, 3187, 2004.
52. Shi, X., Sitharaman, B., Pham, Q.P., Liang, F., Wu, K., Billups, W.E., Wilson, L.J., and Mikos, A.G. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 28, 4078, 2007.
53. Salinas, C.N., Cole, B.B., Kasko, A.M., and Anseth, K.S. Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks. Tissue Eng 13, 1025, 2007.
54. Nuttelman, C.R., Tripodi, M.C., and Anseth, K.S. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res A 68, 773, 2004.
55. Markusen, J.F., Mason, C., Hull, D.A., Town, M.A., Tabor, A.B., Clements, M., Boshoff, C.H., and Dunnill, P. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng 12, 821, 2006.
56. Verron, E., Khairoun, I., Guicheux, J., and Bouler, J.M. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discov Today 15, 547, 2010.
57. Bridwell, K.H., Anderson, P.A., Boden, S.D., Vaccaro, A.R., and Wang, J.C. What's new in spine surgery? J Bone Joint Surg Am 89, 1654, 2007.
58. Yeom, J., Chang, S., Park, J.K., Je, J.H., Yang, D.J., Choi, S.K., Shin, H.I., Lee, S.J., Shim, J.H., Cho, D.W., and Hahn, S.K. Synchrotron X-ray bioimaging of bone regeneration by artificial bone substitute of megagen synthetic bone and hyaluronate hydrogels. Tissue Eng Part CMethods 16, 1059, 2010.